Drugs / TEMSAVIR
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02805556 | Mar → May 2016 | HIV infectious disease | ViiV Healthcare | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TEMSAVIR | ChEMBL registry synonym — accepted as the source's own label CHEMBL3301620 ↗ |
| Known as | BMS-626529 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02805556 ↗ |
| Modality | Small molecule | — CHEMBL3301620 ↗ |
| Route | Intravenous | “Single intravenous dose of \[13C\]BMS 626529” NCT02805556 ↗ |